Apr 28, 2023
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Apr. 28, 2023-- 2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, will announce its first quarter 2023 financial results on Wednesday, May 3, 2023 . 2seventy bio will host a conference call and webcast at 4:30 p.m.
Mar 08, 2023
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Mar. 8, 2023-- 2seventy bio, Inc. (Nasdaq: TSVT) today announced the appointment of Wei Lin , M.D. to the company’s Board of Directors, effective immediately. “We are thrilled to welcome Dr. Wei Lin to 2seventy’s Board during an exciting time in our Company’s